Expression of inducible co-stimulator in peripheral blood T lymphocytes in the patients with systemic lupus erythematosus

Abstract

The expression of inducible co-stimulator (ICOS) in peripheral blood T lymphocytes from the patients with systemic lupus erythematosus (SLE) and the role in the pathogenesis of SLE was investigated. By using two-color immunofluorescent staining and flow cytometric assay, the expression levels of ICOS in peripheal blood T lymphocytes from 33 patients with SLE and 16 healthy volunteers were detected. SLE diseases activity index (SLEDAI) of the patients with SLE was used to evaluate the disease activity. The correlation between the ICOS expression and SLEDAI was analyzed among the groups. The results showed that the expression levels of ICOS in T lymphocytes in active SLE group was markedly higher than those in the control and inactive SLE groups (bothP< 0.01). There was no significant difference in the expression levels of ICOS between the inactive SLE and the control groups (P>0.05). In active SLE and inactive SLE groups, positive linear correlation was found between the levels of the ICOS expression in T lymphocytes and SLEDAI (r=0. 711,P=0.001;r=0.561,P=0.03). It was suggested that the expression of ICOS in peripheral blood T lymphocytes from the patients with active SLE was up-regulated and and ICOS might be related to the pathogenesis of SLE.

Keywords

lupus erythematosus, systemic / inducible co-stimulatory

References

[1] CriscioneL G, PisetskyD S. B lymphocytes and systemic lupus erythematosus. Curr Rheumatol Rep, 2003, 5(4): 264-264

[2] SeoS J, FieldsM L, BucklerJ L, et al.. The impact of T helper and T regulatory cells on the regulation of antidouble-stranded DNA B cells. Immunity, 2002, 16(4): 535-535

[3] HutloffA, DittrichA M, BeierK C, et al.. ICOS is an inducible T-cell costimulator structurally, and functionally related to CD28. Nature, 1999, 397(6716): 263-263

[4] IwaiH, AbeM, HiroseS, et al.. Involvement of inducible costimulator-B7 homologous protein costimulatory pathway in murine lupus nephritis. J Immunol, 2003, 171(6): 2848-2848

[5] BombardierC, GladmanD D, UrowitzM B, et al.. Derivation of the SLEDAI: a disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum, 1992, 35: 630-630

[6] MagesH W, HutloffA, HeuckC, et al.. Molecular cloning and characterization of murine ICOS and identification of B7h as ICOS ligand. Eur J Immunol, 2000, 30(4): 1040-1040

[7] McAdamA J, GreenwaldR J, LevinM A, et al.. Icos is critical for CD40-mediated antibody class switching. Nature, 2001, 409(6816): 102-102

[8] SuhW K, TafuriA, Berg-BrownN N, et al.. The inducible costimulator plays the major costimulatory role in humoral immune responses in the absence of CD28. J Immunol, 2004, 172(10): 5917-5917

[9] HorwitzD A, TangF L, StimmlerM M, et al.. Decrease T cell response to anti-CD2 in systemic lupus erythematosus and reversal by anti-CD28: evidence for imperied T cell-accessory cell interaction. Arthritis Rheum, 1997, 40(5): 822-822